The Department of Justice’s Federal Bureau of Prisons issued a directive on February 19, 2026 titled “Management of Inmates with Gender Dysphoria,” and the text has been condemned as a blueprint for institutionalized conversion therapy. At its core the policy halts or forces the cessation of medical treatment for people with gender dysphoria, orders the removal of clothing and personal items that support a person’s gender expression, and endorses psychotherapy aimed at reducing gender-related feelings. The result is a federal program that uses custody to coerce identity change, targeting people who cannot leave and therefore cannot refuse these measures.
The consequences are immediate and medical: the directive bars new starts of hormone therapy, and for those already receiving it mandates tapering and discontinuation in many cases. The policy also rescinds access to social accommodations — items and allowances that let someone present in a way consistent with their gender — and replaces evidence-based interventions with counseling and psychotropic prescriptions intended to suppress transgender identity. Advocates say this is not treatment but punishment.
What the policy actually requires
Reading the policy closely reveals three interlocking components that create a coercive system. First, there is an explicit prohibition on initiating hormone therapy for inmates who are not already receiving it, while many current recipients face forced tapering. Second, the BOP withdraws and confiscates the social accommodations and personal items that support gender expression, turning everyday necessities into tools of discipline. Third, the directive prioritizes targeted psychotherapy and psychotropic interventions intended to reduce gender dysphoria rather than maintain medically recognized care. Each element alone harms; together they form a deliberate strategy to compel conformity.
How this becomes conversion therapy in practice
The policy meets the commonly used definition of conversion therapy: a set of practices designed to pressure or coerce suppression of sexual orientation or gender identity. By withdrawing established medical care and substituting counseling aimed at changing internal experience, the BOP’s approach uses state authority to pursue outcomes long disavowed by mainstream medicine. Courts and medical organizations have repeatedly recognized that denying necessary treatment to people in custody can constitute cruel and unusual punishment when it risks serious health or psychiatric consequences.
Legal context and ongoing court action
The BOP directive did not arrive into a legal vacuum. A federal judge issued a preliminary injunction in Kingdom v. Trump on June 3, 2026, ordering the agency to continue providing hormone therapy and relevant social accommodations under prior rules. The new policy itself acknowledges that the BOP “remains obligated to comply” with that injunction while still setting out the administration’s preferred rules. Advocates and civil rights groups have flagged this as an explicit intent to implement the policy once litigation or injunctions change.
What advocates are doing
The National Center for Lesbian Rights (NCLR) and other organizations are actively monitoring compliance with the injunction and pursuing additional litigation. NCLR reports it is representing incarcerated transgender people in companion cases that challenge forced placement and exposure to sexual violence and is working to ensure detained people understand their legal protections. Shannon Minter, NCLR’s Legal Director, has led litigation on transgender rights for decades and warns the policy is both unconstitutional and medically dangerous.
Broader pattern and why it matters beyond the transgender community
This BOP policy is one visible strand of a broader effort to remove access to transgender health care across federal systems. Administrative moves have already affected service members, federal employees, and proposed health regulations that would limit Medicaid and Medicare support for providers serving transgender youth. The ripple effects include hospitals and clinics curtailing gender-affirming services out of fear of federal retaliation, subpoenas seeking patient data, and public campaigns aimed at reporting providers. Taken together, these actions are dismantling pathways to care in settings where reliance on institutional permission is greatest.
Constitutional and public stakes
The issue raises urgent constitutional questions under the Eighth Amendment and basic principles of medical ethics. Courts have long recognized that deliberately withholding medically necessary care from people in custody can amount to cruel and unusual punishment. If an agency can redefine what is “medically necessary” based on political preference and impose coercive therapeutic regimes, that power could be turned against any vulnerable group in custody. For anyone concerned about limits on state power and protections for people deprived of liberty, the stakes are substantial.
Advocates promise continued litigation and public exposure. The BOP issued a rule it hoped would remain hidden in bureaucratic filings; instead, civil rights organizations have highlighted every provision as a potential constitutional violation and pledged to fight it in court and public opinion. The debate is no longer abstract: the policies on the table will determine whether people in federal custody retain access to established medical care or are subjected to coercive programs that aim to erase who they are.